Analysis of clinically actionable alterations in baseline tumor versus plasma samples in participants of the TOPAZ-1 study of durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer ...

Dr. Alan Tan spoke with CURE® about what patients with kidney cancer and providers who treat it may be able to learn from ...

Explore how cfDNA levels change around colorectal cancer surgery and their potential as non-invasive biomarkers for ...

Investigators wanted to analyze the diagnostic performance of methylation-sensitive restriction enzyme digestion followed by sequencing using cell-free DNA and explore the cancer signal origin of ...

Ultrasensitive detection of circulating tumor DNA can improve clinical outcomes in aggressive B-cell lymphomas by identifying measurable residual disease. Defining remission is challenging due to ...

Purpose: To seek novel diagnostic approaches, we improved the workflow of cell-free DNA (cfDNA) sequencing and evaluated its feasibility in vitreoretinal ... were sent as soon as possible to the ...

Published in Cell, the study uncovers a novel mode of gene regulation and its role in diseases like cancer, paving the way for personalized therapies using “epigenetic drugs” that target both DNA and ...

Mercy is offering a new, revolutionary cancer screening that can detect around fifty types of cancer even earlier with a ...

Cell-free DNA (cfDNA) is the major structural component of neutrophil extracellular traps (NETs), an innate immune response to infection. Antimicrobial proteins and peptides bound to cfDNA play a ...

Georgia Tech researchers have developed biosensors with advanced sleuthing skills and the technology may revolutionize cancer detection ... the sensors are cell-free, there's a reduced risk ...